These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9549638)

  • 1. Pharmacokinetics of fosinoprilat in Chinese and whites after intravenous administration.
    Hu OY; Ding PY; Huang CS; Hwang GM; Chu KM
    J Clin Pharmacol; 1997 Sep; 37(9):834-40. PubMed ID: 9549638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjects.
    Ding PY; Chu KM; Hu OY; Huang GM; Jeng JJ; Chang A; Delaney CL; MacAskill M; Yang BC; Jemal M; Smith R; Liao WC
    J Clin Pharmacol; 1999 Feb; 39(2):155-60. PubMed ID: 11563407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.
    Ford NF; Lasseter KC; Van Harken DR; Hammett JL; Raymond R; Manning J
    J Clin Pharmacol; 1995 Feb; 35(2):145-50. PubMed ID: 7751424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosinopril/hydrochlorothiazide: single dose and steady-state pharmacokinetics and pharmacodynamics.
    O'Grady P; Yee KF; Lins R; Mangold B
    Br J Clin Pharmacol; 1999 Sep; 48(3):375-81. PubMed ID: 10510149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
    Gehr TW; Sica DA; Grasela DM; Duchin KL
    Eur J Clin Pharmacol; 1993; 45(5):431-6. PubMed ID: 8112372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
    Kostis JB; Garland WT; Delaney C; Norton J; Liao WC
    Clin Pharmacol Ther; 1995 Dec; 58(6):660-5. PubMed ID: 8529331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R; Zucchelli P; Caspi A; Nouriel H; Paz R; Sclarovsky S; O'Grady P; Yee KF; Liao WC; Mangold B
    Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of fosinopril in patients with various degrees of renal function.
    Hui KK; Duchin KL; Kripalani KJ; Chan D; Kramer PK; Yanagawa N
    Clin Pharmacol Ther; 1991 Apr; 49(4):457-67. PubMed ID: 1826651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H; Naruse M; Minamisawa K; Ueda S; Himeno H; Hiroto S; Takasaki I
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosinopril and hydrochlorothiazide combination versus individual components: lack of a pharmacokinetic interaction.
    Uderman HD; Much DR; Brennan J; Delaney CL; Morgenthien EA; Weaver J; Stouffer BC; Chang SY; VanHarken D; Liao W
    Ann Pharmacother; 1999 May; 33(5):525-30. PubMed ID: 10369612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.
    Xue K; Li G; Sun X; Hu Y; Hu L; Huang J; Si L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():141-9. PubMed ID: 25875586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma.
    Cui S; Feng F; Ma M; Liu H; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):143-51. PubMed ID: 17482898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.
    Jemal M; Huang M; Mao Y; Whigan D; Schuster A
    Rapid Commun Mass Spectrom; 2000; 14(12):1023-8. PubMed ID: 10861982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA; Cutler RE; Parmer RJ; Ford NF
    Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.
    Jancic B; Ivanovic D; Medenica M; Malenovic A; Dimkovic N
    J Chromatogr A; 2005 Sep; 1088(1-2):187-92. PubMed ID: 16130750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors?
    Ding PY; Hu OY; Pool PE; Liao W
    J Hum Hypertens; 2000 Mar; 14(3):163-70. PubMed ID: 10694829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
    Duchin KL; Waclawski AP; Tu JI; Manning J; Frantz M; Willard DA
    J Clin Pharmacol; 1991 Jan; 31(1):58-64. PubMed ID: 1646240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pharmacodynamics of fosinopril in patients with congestive heart failure.
    Ford NF; Natarajan C; Fulmor IE; Smith RA; Hui KK
    J Clin Pharmacol; 1995 Aug; 35(8):785-93. PubMed ID: 8522635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.
    Gehr TW; Sica DA; Grasela DM; Fakhry I; Davis J; Duchin KL
    Eur J Clin Pharmacol; 1991; 41(2):165-9. PubMed ID: 1835932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum.
    Jemal M; Mulvana DE
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):255-71. PubMed ID: 10755370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.